Genetic Variations in hTERT May Influence Diabetes Complications Through Pathways Beyond Telomere Length

Researchers examined three specific genetic variants in the hTERT gene—a gene involved in telomere maintenance—to see if they were connected to telomere length and diabetes-related complications. Telomeres are protective caps on DNA that naturally shorten over time. The study included patients with both type 1 and type 2 diabetes and measured the length of telomeres in white blood cells alongside clinical health markers like cholesterol, waist circumference, and nerve damage.

Understanding genetic factors that influence diabetes outcomes matters because it could help explain why some people develop certain complications while others do not, even when their blood sugar management is similar.

The most striking finding was that the three hTERT variants showed no meaningful connection to telomere length in either type 1 or type 2 diabetes patients. This was unexpected, since hTERT is a gene known to regulate telomerase—the enzyme that maintains telomere length.

However, in type 2 diabetes patients, certain genetic variants did show associations with specific health outcomes, independent of telomere length. For example, patients carrying the CC version of the rs2853669 variant had lower odds of developing diabetic neuropathy (nerve damage). The rs2735940 TT variant was linked to a more favorable cholesterol profile. A third variant (rs7712562) showed associations with waist circumference measurements.

These findings are preliminary. The associations did not survive the statistical corrections researchers typically apply when testing multiple genetic variants at once. This means they are best viewed as hypothesis-generating observations rather than confirmed discoveries.

Notably, type 1 diabetes patients did not show these clinical associations, suggesting the genetic effects may work differently depending on diabetes type. The researchers emphasize that these results need independent confirmation in larger, prospective studies before any conclusions can be drawn.

If these findings hold up in future research, they could point to new biological pathways—possibly involving mitochondrial health rather than telomere length alone—that influence how diabetes complications develop.

This study did not identify significant genetic associations in type 1 diabetes patients, so it does not provide new clinical insights for that population at this time. However, the research demonstrates that scientists continue to investigate how genetic variation influences diabetes and its complications, with the goal of one day predicting and preventing complications more effectively.

As genetic research advances, a clearer picture may emerge of how different genes interact with metabolism and diabetes, potentially opening new avenues for targeted prevention and treatment approaches.

Source: International journal of molecular sciences. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.